D-0571-2016 Class III Terminated
FDA drug recall D-0571-2016 was initiated by Morton Grove Pharmaceuticals, Inc. on Dec 15, 2015 and is designated Class III. Reason for recall: Super-Potent Drug: Out of Specification Assay test results were reported for stability samples. The recall status is terminated (terminated Sep 13, 2016). Affected quantity: 39,187 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 27, 2016
- Initiation Date
- Dec 15, 2015
- Termination Date
- Sep 13, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 39,187 bottles
Product description
Lindane Lotion, USP 1%, For External use Only, Rx Only, 2 fl oz (60 mL) bottle, MGP, NDC 60432-833-60
Reason for recall
Super-Potent Drug: Out of Specification Assay test results were reported for stability samples.
Distribution pattern
Nationwide and Puerto Rico
Code information
Lot #: UP1103, Exp 04/2016; UQ1001, Exp 04/2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0571-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026